Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii

Valerie J. Hodgson, David Button, Graeme M. Walker

Research output: Contribution to journalArticle

  • 49 Citations

Abstract

A screening of putative killer yeast strains showed that spore-forming ascomycetous yeasts of the genera Pichia and Williopsis displayed the broadest range of activity against sensitive strains of Candida spp. and Saccharomyces cerevisiae. Williopsis mrakii (NCYC 500) showed extensive anti-Candida activity against strains isolated from clinical specimens. W. mrakii killer factor was produced in minimal media as a function of growth and its activity reached constant levels as cells entered stationary phase. The proteinaceous killer toxin was found to be unstable outwith a specific range of temperature and pH (above 30 °C and pH 4·0), and further analysis showed that the active toxin molecule was an acidic polypeptide with a relative molecular mass between 1·8-5·0 kDa. At critical concentrations the killer factor exerted a greater effect on stationary phase cells of Candida than cells from an exponential phase of growth. At low concentrations, the killer toxin produced a fungistatic effect on sensitive yeasts but at higher concentrations there was evidence to suggest that membrane damage accounted for the zymocidal effects of the killer factor. The cidal nature of the toxin was reflected in a rapid decrease in sensitive cell viability. Findings presented suggest that W. mrakii killer toxin has potential as a novel antimycotic agent in combatting medically important strains of Candida.
Original languageEnglish
Pages (from-to)2003-2012
Number of pages10
JournalMicrobiology
Volume141
Issue number8
DOIs
StatePublished - 1 Aug 1995

Fingerprint

Williopsis
Yeast Killer Factor
Candida
Yeasts
Pichia
Spores
Saccharomyces cerevisiae
Cell Survival
Peptides
Temperature
Membranes

Cite this

Hodgson, Valerie J.; Button, David; Walker, Graeme M. / Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii.

In: Microbiology, Vol. 141, No. 8, 01.08.1995, p. 2003-2012.

Research output: Contribution to journalArticle

@article{a53195e67fe04aa5bf5ec83f7d70ced6,
title = "Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii",
abstract = "A screening of putative killer yeast strains showed that spore-forming ascomycetous yeasts of the genera Pichia and Williopsis displayed the broadest range of activity against sensitive strains of Candida spp. and Saccharomyces cerevisiae. Williopsis mrakii (NCYC 500) showed extensive anti-Candida activity against strains isolated from clinical specimens. W. mrakii killer factor was produced in minimal media as a function of growth and its activity reached constant levels as cells entered stationary phase. The proteinaceous killer toxin was found to be unstable outwith a specific range of temperature and pH (above 30 °C and pH 4·0), and further analysis showed that the active toxin molecule was an acidic polypeptide with a relative molecular mass between 1·8-5·0 kDa. At critical concentrations the killer factor exerted a greater effect on stationary phase cells of Candida than cells from an exponential phase of growth. At low concentrations, the killer toxin produced a fungistatic effect on sensitive yeasts but at higher concentrations there was evidence to suggest that membrane damage accounted for the zymocidal effects of the killer factor. The cidal nature of the toxin was reflected in a rapid decrease in sensitive cell viability. Findings presented suggest that W. mrakii killer toxin has potential as a novel antimycotic agent in combatting medically important strains of Candida.",
author = "Hodgson, {Valerie J.} and David Button and Walker, {Graeme M.}",
year = "1995",
month = "8",
doi = "10.1099/13500872-141-8-2003",
volume = "141",
pages = "2003--2012",
journal = "Microbiology",
issn = "1350-0872",
publisher = "Society for General Microbiology",
number = "8",

}

Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii. / Hodgson, Valerie J.; Button, David; Walker, Graeme M.

In: Microbiology, Vol. 141, No. 8, 01.08.1995, p. 2003-2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-Candida activity of a novel killer toxin from the yeast Williopsis mrakii

AU - Hodgson,Valerie J.

AU - Button,David

AU - Walker,Graeme M.

PY - 1995/8/1

Y1 - 1995/8/1

N2 - A screening of putative killer yeast strains showed that spore-forming ascomycetous yeasts of the genera Pichia and Williopsis displayed the broadest range of activity against sensitive strains of Candida spp. and Saccharomyces cerevisiae. Williopsis mrakii (NCYC 500) showed extensive anti-Candida activity against strains isolated from clinical specimens. W. mrakii killer factor was produced in minimal media as a function of growth and its activity reached constant levels as cells entered stationary phase. The proteinaceous killer toxin was found to be unstable outwith a specific range of temperature and pH (above 30 °C and pH 4·0), and further analysis showed that the active toxin molecule was an acidic polypeptide with a relative molecular mass between 1·8-5·0 kDa. At critical concentrations the killer factor exerted a greater effect on stationary phase cells of Candida than cells from an exponential phase of growth. At low concentrations, the killer toxin produced a fungistatic effect on sensitive yeasts but at higher concentrations there was evidence to suggest that membrane damage accounted for the zymocidal effects of the killer factor. The cidal nature of the toxin was reflected in a rapid decrease in sensitive cell viability. Findings presented suggest that W. mrakii killer toxin has potential as a novel antimycotic agent in combatting medically important strains of Candida.

AB - A screening of putative killer yeast strains showed that spore-forming ascomycetous yeasts of the genera Pichia and Williopsis displayed the broadest range of activity against sensitive strains of Candida spp. and Saccharomyces cerevisiae. Williopsis mrakii (NCYC 500) showed extensive anti-Candida activity against strains isolated from clinical specimens. W. mrakii killer factor was produced in minimal media as a function of growth and its activity reached constant levels as cells entered stationary phase. The proteinaceous killer toxin was found to be unstable outwith a specific range of temperature and pH (above 30 °C and pH 4·0), and further analysis showed that the active toxin molecule was an acidic polypeptide with a relative molecular mass between 1·8-5·0 kDa. At critical concentrations the killer factor exerted a greater effect on stationary phase cells of Candida than cells from an exponential phase of growth. At low concentrations, the killer toxin produced a fungistatic effect on sensitive yeasts but at higher concentrations there was evidence to suggest that membrane damage accounted for the zymocidal effects of the killer factor. The cidal nature of the toxin was reflected in a rapid decrease in sensitive cell viability. Findings presented suggest that W. mrakii killer toxin has potential as a novel antimycotic agent in combatting medically important strains of Candida.

U2 - 10.1099/13500872-141-8-2003

DO - 10.1099/13500872-141-8-2003

M3 - Article

VL - 141

SP - 2003

EP - 2012

JO - Microbiology

T2 - Microbiology

JF - Microbiology

SN - 1350-0872

IS - 8

ER -